UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056091 |
|---|---|
| Receipt number | R000064090 |
| Scientific Title | Evaluation research for an inpatient program of non-illicit substance use disorder |
| Date of disclosure of the study information | 2024/11/07 |
| Last modified on | 2024/11/07 19:21:13 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation research for an inpatient program of non-illicit substance use disorder
Acronym
Evaluation research for an inpatient program of non-illicit substance use disorder
Scientific Title
Evaluation research for an inpatient program of non-illicit substance use disorder
Scientific Title:Acronym
Evaluation research for an inpatient program of non-illicit substance use disorder
Region
| Japan |
Condition
Condition
Non-illicit substance use disorder
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate an effectiveness of newly developed inpatient program for non-illicit substance use disorder
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
SOCRATES-8D Japanese version
(Before the program administration and after the program completion)
Key secondary outcomes
Self efficacy Scale for Drug Dependence
Emotion regulation scale
Brief suicide intent scale
Interpersonal needs questionnaire
UCLA loneliness scale
Beck depression inventory
Beck anxiety inventory
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 12 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with non-illicit substance use disorder who needs inpatient treatment
Key exclusion criteria
Those who meets a diagnosis criteria of illicit substance use disorder
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Kyoji |
| Middle name | |
| Last name | Okita |
Organization
National Center of Neurology and Psychiatry
Division name
Department of Psychiatry
Zip code
187-8551
Address
4-1-1 Ogawa higashi, Kodaira, Tokyo
TEL
042-341-2711
kokita@ncnp.go.jp
Public contact
Name of contact person
| 1st name | Yumi |
| Middle name | |
| Last name | Saito |
Organization
National Center of Neurology and Psychiatry
Division name
Department of Psychiatry
Zip code
187-8551
Address
4-1-1 Ogawa higashi, Kodaira, Tokyo
TEL
042-341-2711
Homepage URL
ysaito@ncnp.go.jp
Sponsor or person
Institute
National Center of Neurology and Psychiatry
Institute
Department
Personal name
Funding Source
Organization
Ministry of Health, Labour and Welfare of Japan
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Center of Neurology and Psychiatry Ethics Committee
Address
4-1-1 Ogawa higashi, Kodaira, Tokyo
Tel
042-341-2711
ml_rinri-jimu@ncnp.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 11 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2024 | Year | 10 | Month | 27 | Day |
Date of IRB
| 2024 | Year | 11 | Month | 07 | Day |
Anticipated trial start date
| 2024 | Year | 11 | Month | 07 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Nothing to report
Management information
Registered date
| 2024 | Year | 11 | Month | 07 | Day |
Last modified on
| 2024 | Year | 11 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064090
